Zobrazeno 1 - 10
of 97
pro vyhledávání: '"Leggett AL"'
Autor:
Yan, Hao1 (AUTHOR), Zang, Ruge1 (AUTHOR) rugezang@163.com, Cui, Tiantian1 (AUTHOR), Liu, Yiming1 (AUTHOR), Zhang, Biao1 (AUTHOR), Zhao, Lingpin1 (AUTHOR), Li, Hongyu1 (AUTHOR), Zhou, Juannian1 (AUTHOR), Wang, Haiyang1 (AUTHOR), Zeng, Quan1 (AUTHOR), Xu, Lei1 (AUTHOR), Zhou, Yuqi1 (AUTHOR), Pei, Xuetao1 (AUTHOR), Xi, Jiafei1 (AUTHOR) xi_jiafei@126.com, Yue, Wen1 (AUTHOR) yuewen@bmi.ac.cn
Publikováno v:
Stem Cell Research & Therapy. 9/18/2024, Vol. 15 Issue 1, p1-15. 15p.
Autor:
Nabet B; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA. behnam_nabet@dfci.harvard.edu.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA. behnam_nabet@dfci.harvard.edu., Ferguson FM; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Seong BKA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Kuljanin M; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Leggett AL; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA., Mohardt ML; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA., Robichaud A; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Conway AS; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Buckley DL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Mancias JD; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Bradner JE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Stegmaier K; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA., Gray NS; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA. nathanael_gray@dfci.harvard.edu.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA. nathanael_gray@dfci.harvard.edu.
Publikováno v:
Nature communications [Nat Commun] 2020 Sep 18; Vol. 11 (1), pp. 4687. Date of Electronic Publication: 2020 Sep 18.
Autor:
Liu Y; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States.; Department of Cancer Biology, Dana Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02215, United States., Hao M; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States.; Department of Cancer Biology, Dana Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02215, United States., Leggett AL; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States.; Department of Cancer Biology, Dana Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02215, United States., Gao Y; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States.; Department of Cancer Biology, Dana Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02215, United States., Ficarro SB; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States.; Department of Cancer Biology, Dana Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02215, United States.; Blais Proteomics Center, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02215, United States., Che J; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States.; Department of Cancer Biology, Dana Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02215, United States., He Z; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States.; Department of Cancer Biology, Dana Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02215, United States., Olson CM; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States.; Department of Cancer Biology, Dana Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02215, United States., Marto JA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States.; Department of Cancer Biology, Dana Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02215, United States.; Blais Proteomics Center, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02215, United States., Kwiatkowski NP; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States.; Department of Cancer Biology, Dana Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02215, United States., Zhang T; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States.; Department of Cancer Biology, Dana Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02215, United States., Gray NS; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States.; Department of Cancer Biology, Dana Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02215, United States.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2020 Jul 09; Vol. 63 (13), pp. 6708-6726. Date of Electronic Publication: 2020 Jun 25.
Autor:
Ferguson FM; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Nabet B; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Raghavan S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Liu Y; Departments of Biochemistry and Radiation Oncology, the University of Texas Southwestern Medical Center, Dallas, TX, USA., Leggett AL; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA., Kuljanin M; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Kalekar RL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Yang A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., He S; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Wang J; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Ng RWS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Sulahian R; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Li L; Departments of Biochemistry and Radiation Oncology, the University of Texas Southwestern Medical Center, Dallas, TX, USA., Poulin EJ; Cancer Research Institute and Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Huang L; Cancer Research Institute and Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Koren J; Department of Molecular and Human Genetics, Therapeutic Innovation Center Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX, USA., Dieguez-Martinez N; Departament de Bioquímica i Biologia Molecular & Institut de Neurociencies, Facultat de Medicina. Universitat Autonoma de Barcelona, Bellaterra, Spain., Espinosa S; Departament de Bioquímica i Biologia Molecular & Institut de Neurociencies, Facultat de Medicina. Universitat Autonoma de Barcelona, Bellaterra, Spain., Zeng Z; Promega Corporation, Madison, WI, USA., Corona CR; Promega Corporation, Madison, WI, USA., Vasta JD; Promega Corporation, Madison, WI, USA., Ohi R; Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI, USA., Sim T; Chemical Kinomics Research Center, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea and KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul, Republic of Korea., Kim ND; NDBio Therapeutics Inc, Incheon, Republic of Korea., Harshbarger W; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; GSK Vaccines, Rockville, MD, USA., Lizcano JM; Departament de Bioquímica i Biologia Molecular & Institut de Neurociencies, Facultat de Medicina. Universitat Autonoma de Barcelona, Bellaterra, Spain., Robers MB; Promega Corporation, Madison, WI, USA., Muthaswamy S; Cancer Research Institute and Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Departments of Medicine and Pathology, Harvard Medical School, Boston, MA, USA., Lin CY; Department of Molecular and Human Genetics, Therapeutic Innovation Center Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX, USA., Look AT; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA., Haigis KM; Cancer Research Institute and Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Harvard Digestive Disease Center, Harvard Medical School, Boston, MA, USA., Mancias JD; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Aguirre AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Hahn WC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Westover KD; Departments of Biochemistry and Radiation Oncology, the University of Texas Southwestern Medical Center, Dallas, TX, USA., Gray NS; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA. nathanael_gray@dfci.harvard.edu.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA. nathanael_gray@dfci.harvard.edu.
Publikováno v:
Nature chemical biology [Nat Chem Biol] 2020 Jun; Vol. 16 (6), pp. 635-643. Date of Electronic Publication: 2020 Apr 06.
Autor:
Schwaiger, Michaela1,2 (AUTHOR), Mohn, Fabio1 (AUTHOR), Bühler, Marc1,3 (AUTHOR), Kaaij, Lucas J. T.4 (AUTHOR) l.j.t.kaaij-2@umcutrecht.nl
Publikováno v:
BMC Genomics. 7/29/2024, Vol. 25 Issue 1, p1-23. 23p.
Autor:
Zeng M; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, United States.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States., Kwiatkowski NP; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, United States.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States., Zhang T; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, United States.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States., Nabet B; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, United States.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States., Xu M; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, United States.; Department of Medicine, Harvard Medical School, Boston, United States., Liang Y; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, United States.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States., Quan C; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, United States.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States., Wang J; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, United States.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States., Hao M; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, United States.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States., Palakurthi S; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, United States., Zhou S; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, United States., Zeng Q; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, United States., Kirschmeier PT; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, United States., Meghani K; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, United States., Leggett AL; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, United States.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States., Qi J; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, United States.; Department of Medicine, Harvard Medical School, Boston, United States., Shapiro GI; Early Drug Development Center, Dana-Farber Cancer Institute, Boston, United States., Liu JF; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States., Matulonis UA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States., Lin CY; Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, United States.; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States., Konstantinopoulos PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States., Gray NS; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, United States.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States.
Publikováno v:
ELife [Elife] 2018 Nov 13; Vol. 7. Date of Electronic Publication: 2018 Nov 13.
Autor:
Nabet B; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Roberts JM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Buckley DL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Paulk J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Dastjerdi S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Yang A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Leggett AL; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA., Erb MA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Lawlor MA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Souza A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Scott TG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Vittori S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Perry JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Qi J; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Winter GE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; CeMM- Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Wong KK; Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, NY, USA., Gray NS; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA. nathanael_gray@dfci.harvard.edu.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA. nathanael_gray@dfci.harvard.edu., Bradner JE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. james.bradner@novartis.com.; Department of Medicine, Harvard Medical School, Boston, MA, USA. james.bradner@novartis.com.; Novartis Institutes for BioMedical Research, Cambridge, MA, USA. james.bradner@novartis.com.
Publikováno v:
Nature chemical biology [Nat Chem Biol] 2018 May; Vol. 14 (5), pp. 431-441. Date of Electronic Publication: 2018 Mar 26.
Autor:
Hatcher JM; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA., Wu G; Department of Cellular and Molecular Medicine, Institute of Genomic Medicine, University of California, San Diego, La Jolla, CA 92093, USA., Zeng C; School of Life Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong Special Administrative Region NA, China., Zhu J; Shiley Eye Institute, Institute for Engineering in Medicine, Institute for Genomic Medicine, University of California, San Diego, La Jolla, CA 92093, USA; Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou 510623, China., Meng F; Department of Cellular and Molecular Medicine, Institute of Genomic Medicine, University of California, San Diego, La Jolla, CA 92093, USA., Patel S; Shiley Eye Institute, Institute for Engineering in Medicine, Institute for Genomic Medicine, University of California, San Diego, La Jolla, CA 92093, USA., Wang W; Shiley Eye Institute, Institute for Engineering in Medicine, Institute for Genomic Medicine, University of California, San Diego, La Jolla, CA 92093, USA., Ficarro SB; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Oncologic Pathology and Blais Proteomics Center, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA., Leggett AL; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA., Powell CE; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA., Marto JA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Oncologic Pathology and Blais Proteomics Center, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA., Zhang K; Shiley Eye Institute, Institute for Engineering in Medicine, Institute for Genomic Medicine, University of California, San Diego, La Jolla, CA 92093, USA., Ki Ngo JC; School of Life Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong Special Administrative Region NA, China., Fu XD; Department of Cellular and Molecular Medicine, Institute of Genomic Medicine, University of California, San Diego, La Jolla, CA 92093, USA. Electronic address: xdfu@ucsd.edu., Zhang T; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA. Electronic address: tinghu_zhang@dfci.harvard.edu., Gray NS; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA. Electronic address: nathanael_gray@dfci.harvard.edu.
Publikováno v:
Cell chemical biology [Cell Chem Biol] 2018 Apr 19; Vol. 25 (4), pp. 460-470.e6. Date of Electronic Publication: 2018 Feb 22.
Autor:
Rusan M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Cancer Program, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts., Li K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Dermatology, Chung-Ang University College of Medicine, Seoul, Korea., Li Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Cancer Program, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts., Christensen CL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Abraham BJ; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts., Kwiatkowski N; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts., Buczkowski KA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Bockorny B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Cancer Program, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts.; Division of Hematology and Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Chen T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Li S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Rhee K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Zhang H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Chen W; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Anesthesiology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Terai H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Tavares T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Leggett AL; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts., Li T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Wang Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Zhang T; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts., Kim TJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul, Korea., Hong SH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Poudel-Neupane N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Silkes M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Mudianto T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Tan L; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts., Shimamura T; Molecular Pharmacology and Therapeutics, Oncology Research Institute, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois., Meyerson M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Cancer Program, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts., Bass AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Cancer Program, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts.; Departments of Medicine, Brigham & Women's Hospital and Harvard Medical School, Boston, Massachusetts., Watanabe H; Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine and Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Gray NS; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts., Young RA; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts.; Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts., Wong KK; Laura & Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York., Hammerman PS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. peter.hammerman@novartis.com.; Cancer Program, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts.; Novartis Institutes of Biomedical Research, Cambridge, Massachusetts.
Publikováno v:
Cancer discovery [Cancer Discov] 2018 Jan; Vol. 8 (1), pp. 59-73. Date of Electronic Publication: 2017 Oct 20.
Autor:
Thompson JK; Department of Pathology and Laboratory Medicine, Larner College of Medicine, University of Vermont, Burlington, VT 05405, USA., Shukla A; Department of Pathology and Laboratory Medicine, Larner College of Medicine, University of Vermont, Burlington, VT 05405, USA., Leggett AL; Department of Pathology and Laboratory Medicine, Larner College of Medicine, University of Vermont, Burlington, VT 05405, USA., Munson PB; Department of Pathology and Laboratory Medicine, Larner College of Medicine, University of Vermont, Burlington, VT 05405, USA., Miller JM; Department of Pathology and Laboratory Medicine, Larner College of Medicine, University of Vermont, Burlington, VT 05405, USA., MacPherson MB; Department of Pathology and Laboratory Medicine, Larner College of Medicine, University of Vermont, Burlington, VT 05405, USA., Beuschel SL; Department of Pathology and Laboratory Medicine, Larner College of Medicine, University of Vermont, Burlington, VT 05405, USA., Pass HI; Department of Cardiothoracic Surgery, Langone Medical Center, New York University, New York, NY 10012, USA., Shukla A; Department of Pathology and Laboratory Medicine, Larner College of Medicine, University of Vermont, Burlington, VT 05405, USA.
Publikováno v:
Oncotarget [Oncotarget] 2017 Dec 06; Vol. 9 (1), pp. 293-305. Date of Electronic Publication: 2017 Dec 06 (Print Publication: 2018).